Powel H. Brown

15.8k citations

223 papers · 10.1k indexed · 3 hit papers · h-index 54

Molecular Biology top 1%
Oncology top 0.5%
Cancer Research top 0.5%
Genetics top 0.5%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Susan G. Hilsenbeck Michelle I. Savage Abhijit Mazumdar Anna Tsimelzon Iván P. Uray Gordon B. Mills Michael J. Birrer M. J. Birrer
Topics: Estrogen and related hormone effects (74 papers)Retinoids in leukemia and cellular processes (42 papers)Cancer-related Molecular Pathways (35 papers)
Cited by: Cancer Research Oncology Genetics
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Italy United Kingdom

In The Last Decade

Powel H. Brown

219 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

2014 936 citations Matthew D. Burstein, Anna Tsimelzon et al. Clinical Cancer Research profile →
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

2009 568 citations Powel H. Brown, Frank L. Meyskens et al. profile →
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors

2015 358 citations Jianfeng Shen, Yang Peng et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Powel H. Brown

Since Specialization

Citations

This map shows the geographic impact of Powel H. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Powel H. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Powel H. Brown more than expected).

Fields of papers citing papers by Powel H. Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Powel H. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Powel H. Brown. The network helps show where Powel H. Brown may publish in the future.

Co-authorship network of co-authors of Powel H. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Powel H. Brown. A scholar is included among the top collaborators of Powel H. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Powel H. Brown. Powel H. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth 2024 ·Breast Cancer Research ·Jing Qian,Yanxia Ma,(unknown),(unknown),(unknown),Jamal Hill,(unknown),(unknown),Susan G. Hilsenbeck,Michelle I. Savage,Brent D. G. Page,Abhijit Mazumdar,Powel H. Brown	5
2	638 Nous-209 vaccine induces shared neoantigen immunogenicity for cancer interception in healthy lynch syndrome carriers: results from phase Ib/II trial 2024 ·Regular and Young Investigator Award Abstracts ·Eduardo Vilar,Jason Willis,(unknown),Michael J. Hall,Marcia Cruz‐Correa,Gregory Idos,Selvi Thirumurthi,Guido Leoni,(unknown),Laura Antonucci,Sven Gogov,Wenli Dong,J. Jack Lee,Lana A. Vornik,Araceli García-González,Ellen Richmond,Asad Umar,Powel H. Brown,Luz M. Rodriguez,Elisa Scarselli	1
3	Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia 2024 ·Cancer Prevention Research ·(unknown),(unknown),Usama Khamis Hussein,(unknown),(unknown),Tingting Mills,Lana A. Vornik,Michelle I. Savage,Shizuko Sei,John L. Clifford,Holger K. Eltzschig,Powel H. Brown,Zhongming Zhao,Florencia McAllister,Jennifer M. Bailey	2
4	380 The kinesin-like protein Kif11 is essential for the survival of TP53 mutant triple-negative breast cancer cells 2023 ·Journal of Clinical and Translational Science ·(unknown),(unknown),(unknown),Powel H. Brown	1
5	Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer 2022 ·Cancer Prevention Research ·Abhijit Mazumdar,(unknown),Jamal Hill,(unknown),(unknown),Jitesh D. Kawedia,Jing Qian,Alejandro Contreras,Michelle I. Savage,Lana A. Vornik,Shizuko Sei,Altaf Mohammed,Powel H. Brown	4
6	Energy Balance Modulation Impacts Epigenetic Reprogramming, ERα and ERβ Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice 2017 ·Cancer Research ·Emily L. Rossi,Sarah M. Dunlap,Laura W. Bowers,Subreen A. Khatib,(unknown),Laura Smith,Nikki A. Ford,Darcy Holley,Powel H. Brown,Marcos R. Estecio,Donna F. Kusewitt,Linda A. deGraffenried,Scott J. Bultman,Stephen D. Hursting	22
7	Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance 2016 ·Molecular Cancer Research ·Luca Malorni,Mario Giuliano,Ilenia Migliaccio,Tao Wang,Chad J. Creighton,Mathieu Lupien,Xiaoyong Fu,Susan G. Hilsenbeck,Nuala Healy,Carmine De Angelis,Abhijit Mazumdar,Meghana V. Trivedi,Suleiman Massarweh,Carolina Gutiérrez,Sabino De Placido,Rinath Jeselsohn,Myles Brown,Powel H. Brown,C. Kent Osborne,Rachel Schiff	31
8	Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival 2016 ·Cancer Research ·Petra den Hollander,(unknown),Anna Tsimelzon,Jonathan H. Shepherd,Abhijit Mazumdar,Jamal Hill,Suzanne A.W. Fuqua,Jenny C. Chang,C. Kent Osborne,Susan G. Hilsenbeck,Gordon B. Mills,Powel H. Brown	70
9	ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitorsbreakdown → 2015 ·Cancer Discovery ·Jianfeng Shen,Yang Peng,Leizhen Wei,Wei Zhang,Lin Yang,Li Lan,Prabodh Kapoor,Zhenlin Ju,Qianxing Mo,Ie‐Ming Shih,Iván P. Uray,Xiangwei Wu,Powel H. Brown,(unknown),Gordon B. Mills,Guang Peng	358
10	Molecular cancer prevention: Current status and future directions 2015 ·CA A Cancer Journal for Clinicians ·Karen Colbert Maresso,Kenneth Y. Tsai,Powel H. Brown,Éva Szabó,Scott M. Lippman,Ernest T. Hawk	67
11	Plasma Tocopherols and Risk of Prostate Cancer in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) 2014 ·Cancer Prevention Research ·Demetrius Albanes,Cathee Till,Eric A. Klein,Phyllis J. Goodman,Alison M. Mondul,Stephanie J. Weinstein,Philip R. Taylor,Howard L. Parnes,J. Michael Gaziano,Xiaoling Song,Neil Fleshner,Powel H. Brown,Frank L. Meyskens,Ian M. Thompson	49
12	Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancerbreakdown → 2014 ·Clinical Cancer Research ·Matthew D. Burstein,Anna Tsimelzon,Graham M. Poage,Kyle R. Covington,Alejandro Contreras,Suzanne A.W. Fuqua,Michelle I. Savage,C. Kent Osborne,Susan G. Hilsenbeck,Jenny C. Chang,Gordon B. Mills,Ching C. Lau,Powel H. Brown	936
13	Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8 2013 ·Cancer Research ·Zachary C. Hartman,Graham M. Poage,Petra den Hollander,Anna Tsimelzon,Jamal Hill,Nattapon Panupinthu,Yun Zhang,Abhijit Mazumdar,Susan G. Hilsenbeck,Gordon B. Mills,Powel H. Brown	341
14	Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer 2012 ·Cancer Prevention Research ·Katherine D. Crew,Powel H. Brown,Heather Greenlee,Therese B. Bevers,Banu Arun,Clifford A. Hudis,Heather L. McArthur,Jenny C. Chang,Mothaffar F. Rimawi,Lana A. Vornik,Terri L. Cornelison,Antai Wang,Hanina Hibshoosh,Aqeel Ahmed,Mary Beth Terry,Regina M. Santella,Scott M. Lippman,Dawn L. Hershman	76
15	Identification of Modulated Genes by Three Classes of Chemopreventive Agents at Preneoplastic Stages in a p53-Null Mouse Mammary Tumor Model 2009 ·Cancer Prevention Research ·Martı́n C. Abba,Yuhui Hu,(unknown),Sally Gaddis,Frances Kittrell,Jamal Hill,Reid P. Bissonnette,Powel H. Brown,Daniel Medina,C. Marcelo Aldaz	7
16	Prevention of Tumorigenesis in p53-Null Mammary Epithelium by Rexinoid Bexarotene, Tyrosine Kinase Inhibitor Gefitinib, and Celecoxib 2009 ·Cancer Prevention Research ·Daniel Medina,Frances Kittrell,Jamal Hill,Yun Zhang,Susan G. Hilsenbeck,(unknown),Powel H. Brown	11
17	Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer 2009 ·Clinical Cancer Research ·Corey Speers,Anna Tsimelzon,K. Sexton,(unknown),Carolina Gutiérrez,Aedín C. Culhane,John Quackenbush,Susan G. Hilsenbeck,Jenny C. Chang,Powel H. Brown	77
18	Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells 2009 ·Cancer Research ·Lü Chen,Julie Ann Mayer,Tibor I. Krisko,Corey Speers,Tao Wang,Susan G. Hilsenbeck,Powel H. Brown	115
19	Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase/Activator Protein-1 Signaling to Regulate Cell Migration 2006 ·Cancer Research ·Xiaojiang Cui,Hyun Jung Kim,Isere Kuiatse,Heetae Kim,Powel H. Brown,Adrian V. Lee	62
20	Identification of Biomarkers Modulated by the Rexinoid LGD1069 (Bexarotene) in Human Breast Cells Using Oligonucleotide Arrays 2006 ·Cancer Research ·Hee-Tae Kim,Gu Kong,David G. DeNardo,Yuxin Li,Iván P. Uray,Sunita Pal,Syed K. Mohsin,Susan G. Hilsenbeck,Reid P. Bissonnette,William W. Lamph,Karen A. Johnson,Powel H. Brown	38

About Powel H. Brown

Powel H. Brown is a scholar working on Oncology, Genetics and Cancer Research, having authored 223 papers that have together received 10.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (74 papers), Retinoids in leukemia and cellular processes (42 papers) and Cancer-related Molecular Pathways (35 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (3.9k citations) and Genetics (2.3k citations). Powel H. Brown has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Susan G. Hilsenbeck, Michelle I. Savage, Abhijit Mazumdar, Anna Tsimelzon, Iván P. Uray, Gordon B. Mills, Michael J. Birrer, M. J. Birrer, Scott M. Lippman and Graham M. Poage. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact